Minerva medica最新文献

筛选
英文 中文
Detection method of inflammatory cells in cytopathological images of chronic rhinosinusitis. 慢性鼻炎细胞病理图像中炎性细胞的检测方法。
Minerva medica Pub Date : 2024-10-29 DOI: 10.23736/S0026-4806.24.09384-4
Xiao Yu, Suying Wang, Bingxian Chen, Kun Gui, Kai Wang
{"title":"Detection method of inflammatory cells in cytopathological images of chronic rhinosinusitis.","authors":"Xiao Yu, Suying Wang, Bingxian Chen, Kun Gui, Kai Wang","doi":"10.23736/S0026-4806.24.09384-4","DOIUrl":"https://doi.org/10.23736/S0026-4806.24.09384-4","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of uniportal thoracoscopic segmentectomy on long-term survival in elderly patients with stage I non-small cell lung cancer. 单孔胸腔镜分段切除术对 I 期非小细胞肺癌老年患者长期生存的影响。
Minerva medica Pub Date : 2024-10-11 DOI: 10.23736/S0026-4806.24.09547-8
Shi Chen, Wei Xu
{"title":"Impact of uniportal thoracoscopic segmentectomy on long-term survival in elderly patients with stage I non-small cell lung cancer.","authors":"Shi Chen, Wei Xu","doi":"10.23736/S0026-4806.24.09547-8","DOIUrl":"https://doi.org/10.23736/S0026-4806.24.09547-8","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142402484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venous thromboembolism during pregnancy and postpartum period: an updated review. 孕期和产后静脉血栓栓塞:最新综述。
Minerva medica Pub Date : 2024-10-11 DOI: 10.23736/S0026-4806.24.09242-5
Sanaullah Mojaddedi, Javairia Jamil, Andrew Abraham, Dawood Jamil, Hend Mansoor, Islam Y Elgendy
{"title":"Venous thromboembolism during pregnancy and postpartum period: an updated review.","authors":"Sanaullah Mojaddedi, Javairia Jamil, Andrew Abraham, Dawood Jamil, Hend Mansoor, Islam Y Elgendy","doi":"10.23736/S0026-4806.24.09242-5","DOIUrl":"https://doi.org/10.23736/S0026-4806.24.09242-5","url":null,"abstract":"<p><p>Venous thromboembolism (VTE) is a leading cause of maternal mortality. The risk of VTE in pregnant and postpartum women is ~ five times higher compared with non-pregnant women. There is a physiological tendency to a hypercoagulable state, from conception to the postpartum period. Several non-obstetric risk factors independently increase the risk of VTE. Since most signs and symptoms of VTE might mimic those of a normal pregnancy, a high index of suspicion is warranted to establish the diagnosis. D-dimer, ultrasonography and computed tomography pulmonary angiography are the primary tools for VTE diagnosis. Management mainly revolves around systemic anticoagulation with heparin. Advanced therapy options exist, but these can be considered for selected high-risk cases.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142402497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of biomarkers and construction of a clinical-radiomics model for predicting functional outcome in acute ischemic stroke. 鉴定生物标记物并构建临床放射组学模型,以预测急性缺血性中风的功能预后。
Minerva medica Pub Date : 2024-10-11 DOI: 10.23736/S0026-4806.24.09502-8
Pahati Tuxunjiang, Hanjiaerbieke Kukun, Wei Zhao, Rui Xu, Ainikaerjiang Aihemaiti, Shuang Ding, Shaoyu Wang, Yunling Wang
{"title":"Identification of biomarkers and construction of a clinical-radiomics model for predicting functional outcome in acute ischemic stroke.","authors":"Pahati Tuxunjiang, Hanjiaerbieke Kukun, Wei Zhao, Rui Xu, Ainikaerjiang Aihemaiti, Shuang Ding, Shaoyu Wang, Yunling Wang","doi":"10.23736/S0026-4806.24.09502-8","DOIUrl":"https://doi.org/10.23736/S0026-4806.24.09502-8","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142402483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BNT162b2 vaccine booster dose did not influence the activity of the exudative form of age-related macular degeneration during anti-vascular endothelial growth factor therapy. 在抗血管内皮生长因子治疗期间,BNT162b2 疫苗加强剂量不会影响老年性黄斑变性渗出型的活性。
Minerva medica Pub Date : 2024-10-11 DOI: 10.23736/S0026-4806.24.09379-0
Bernadetta Płatkowska-Adamska, Agnieszka Bociek, Magdalena Kal, Dorota Zarębska-Michaluk, Dominik Odrobina
{"title":"BNT162b2 vaccine booster dose did not influence the activity of the exudative form of age-related macular degeneration during anti-vascular endothelial growth factor therapy.","authors":"Bernadetta Płatkowska-Adamska, Agnieszka Bociek, Magdalena Kal, Dorota Zarębska-Michaluk, Dominik Odrobina","doi":"10.23736/S0026-4806.24.09379-0","DOIUrl":"10.23736/S0026-4806.24.09379-0","url":null,"abstract":"<p><strong>Background: </strong>Due to safety concerns, patients were hesitant to receive a booster dose of COVID-19 vaccine. In this study, we investigated whether neovascular age-related macular degeneration activity deteriorated after receiving the booster dose of the BNT162b2 vaccine.</p><p><strong>Methods: </strong>Optical coherence tomography (OCT) of the macula, best-corrected visual acuity (BCVA), and slit-lamp examination data were collected from 89 patients. All these individuals were diagnosed with neovascular age-related macular degeneration (AMD) and treated with intravitreal injections of aflibercept or ranibizumab. During the process of treatment, patients received a booster dose of the BNT162b2 vaccine. Time points included two visits before (marked as \"-2\", \"-1\") and two visits after (marked as \"1\", \"2\") the uptake of the booster dose.</p><p><strong>Results: </strong>There were significant differences in the average thickness and total volume of the macula during follow-up. Moreover, a decreased average thickness, total volume, total thickness of the macula, subretinal fluid thickness, and subretinal complex thickness was observed between the time points \"-2\" and \"2\", but only in the aflibercept group. There were no significant differences in the frequency of occurring intraretinal cysts, subretinal fluid, serous retinal pigment epithelial detachments retinal hemorrhage, subretinal hyperreflective material, complete RPE and outer retinal atrophy, and BCVA before and after the booster dose.</p><p><strong>Conclusions: </strong>These results demonstrate that the BNT162b2 vaccine booster dose did not deteriorate the course of neovascular AMD.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142402482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Italian Cardiological Guidelines (COCIS) for Competitive Sport Eligibility in athletes with heart disease: update 2024. 意大利心脏病运动员竞技体育资格指南(COCIS):2024 年更新版。
Minerva medica Pub Date : 2024-10-01 DOI: 10.23736/S0026-4806.24.09519-3
Paolo Zeppilli, Alessandro Biffi, Michela Cammarano, Silvia Castelletti, Elena Cavarretta, Franco Cecchi, Furio Colivicchi, Maurizio Contursi, Domenico Corrado, Antonello D'Andrea, Francesco Deferrari, Pietro Delise, Antonio Dello Russo, Domenico Gabrielli, Franco Giada, Ciro Indolfi, Viviana Maestrini, Giuseppe Mascia, Lucio Mos, Fabrizio Oliva, Zefferino Palamà, Stefano Palermi, Vincenzo Palmieri, Giampiero Patrizi, Antonio Pelliccia, Pasquale Perrone Filardi, Italo Porto, Peter J Schwartz, Marco Scorcu, Fabrizio Sollazzo, Andrea Spampinato, Andrea Verzeletti, Alessandro Zorzi, Flavio D'Ascenzi, Maurizio Casasco, Luigi Sciarra
{"title":"Italian Cardiological Guidelines (COCIS) for Competitive Sport Eligibility in athletes with heart disease: update 2024.","authors":"Paolo Zeppilli, Alessandro Biffi, Michela Cammarano, Silvia Castelletti, Elena Cavarretta, Franco Cecchi, Furio Colivicchi, Maurizio Contursi, Domenico Corrado, Antonello D'Andrea, Francesco Deferrari, Pietro Delise, Antonio Dello Russo, Domenico Gabrielli, Franco Giada, Ciro Indolfi, Viviana Maestrini, Giuseppe Mascia, Lucio Mos, Fabrizio Oliva, Zefferino Palamà, Stefano Palermi, Vincenzo Palmieri, Giampiero Patrizi, Antonio Pelliccia, Pasquale Perrone Filardi, Italo Porto, Peter J Schwartz, Marco Scorcu, Fabrizio Sollazzo, Andrea Spampinato, Andrea Verzeletti, Alessandro Zorzi, Flavio D'Ascenzi, Maurizio Casasco, Luigi Sciarra","doi":"10.23736/S0026-4806.24.09519-3","DOIUrl":"10.23736/S0026-4806.24.09519-3","url":null,"abstract":"<p><p>Nearly 35 years after its initial publication in 1989, the Italian Society of Sports Cardiology and the Italian Federation of Sports Medicine (FMSI), in collaboration with other leading Italian Cardiological Scientific Associations (ANCE - National Association of Outpatient Cardiology, ANMCO - National Association of Inpatient Cardiology, SIC - Italian Society of Cardiology), proudly present the 2023 version of the Cardiological Guidelines for Competitive Sports Eligibility. This publication is an update of the previous guidelines, offering a comprehensive and detailed guide for the participation of athletes with heart disease in sports. This edition incorporates the latest advances in cardiology and sports medicine, providing current information and recommendations. It addresses various topics, including the details of the pre-participation screening in Italy and recommendations for sports eligibility and disqualification in competitive athletes with various heart conditions. This revised version of the Cardiological Guidelines for Competitive Sports Eligibility, recorded in the Italian Guidelines Registry of the Italian Minister of Health, stands as a crucial resource for sports medicine professionals, cardiologists, and healthcare providers, marked by its completeness, reliability, and scientific thoroughness. It is an indispensable tool for those involved in the care, management and eligibility process of competitive athletes with heart conditions.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative flow ratio for the functional assessment of extracranial internal carotid artery stenosis. 用于颅外颈内动脉狭窄功能评估的定量血流比值。
Minerva medica Pub Date : 2024-10-01 Epub Date: 2024-07-17 DOI: 10.23736/S0026-4806.24.09350-9
Luigi DI Serafino, Eugenio Stabile, Giuseppe Giugliano, Raffaele Piccolo, Michele Franzese, Carlo Carbone, Lucia Mitrano, Maria L DE Rosa, Salvatore Esposito, Luca Bardi, Maria Scalamogna, Giovanni Esposito
{"title":"Quantitative flow ratio for the functional assessment of extracranial internal carotid artery stenosis.","authors":"Luigi DI Serafino, Eugenio Stabile, Giuseppe Giugliano, Raffaele Piccolo, Michele Franzese, Carlo Carbone, Lucia Mitrano, Maria L DE Rosa, Salvatore Esposito, Luca Bardi, Maria Scalamogna, Giovanni Esposito","doi":"10.23736/S0026-4806.24.09350-9","DOIUrl":"10.23736/S0026-4806.24.09350-9","url":null,"abstract":"<p><strong>Background: </strong>In asymptomatic patients presenting with significant internal carotid artery (ICA) stenoses undergoing endovascular revascularization, a selective angiography before stenting (CAS) is required. Sometimes, angiographic findings could be discordant from non-invasive assessment and a tool able to evaluate functional relevance of the stenosis could be of value. We sought to evaluate the usefulness of quantitative flow ratio (QFR) as angiography-based tool for functional assessment of ICA stenoses.</p><p><strong>Methods: </strong>We prospectively enrolled 50 asymptomatic patients undergoing CAS. Peak systolic velocity (PSV, cm/s) assessed at color Doppler echocardiography was used to identify significant stenoses (PSV >125 cm/s). At angiography, assessment of ICA stenosis was obtained visually (%DS<inf>VISUAL</inf>) and according NASCET criteria (%DS<inf>NASCET</inf>). Stenoses were considered significant if >60%. After exclusion of 20 vessels, QFR, area stenosis (AS, %) and minimal lumen area (MLA, mm<sup>2</sup>) were obtained in the remaining 80 vessels.</p><p><strong>Results: </strong>At linear regression analysis, QFR significantly correlated with PSV (r<sup>2</sup>=0.52, P<0.001) as well as with %DS<inf>NASCET</inf> (r<sup>2</sup>=0.68, P<0.001) and %DS<inf>VISUAL</inf> (r<sup>2</sup>=0.71, P<0.001). Using PSV as reference, QFR showed good accuracy to predict functionally significant stenosis (AUC=0.98, P<0.001) with a cut-off value of 0.93. As compared with %DS<inf>NASCET</inf> and %DS<inf>VISUAL</inf>, QFR showed a significantly higher accuracy (61% vs. 73% vs. 94%, respectively; P<0.05), sensitivity (43% vs. 61% vs. 93%, respectively; P<0.05) and negative predictive value (46% vs. 51% vs. 85%, respectively; P<0.05) for detecting hemodynamically significant ICA stenoses.</p><p><strong>Conclusions: </strong>This study suggest the potential benefit of adopting QFR for functional assessment of extracranial ICA stenoses. These data should be validated in larger studies.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic pyelolithotomy for the treatment of large renal stones: a single-center experience over seven years. 机器人肾盂切开术治疗巨大肾结石:单中心七年来的经验。
Minerva medica Pub Date : 2024-10-01 Epub Date: 2024-07-04 DOI: 10.23736/S0026-4806.24.09291-7
Stefano Moretto, Michele Zazzara, Filippo Marino, Arjan Nazaraj, Marcello Scarcia, Giuseppe M Ludovico
{"title":"Robotic pyelolithotomy for the treatment of large renal stones: a single-center experience over seven years.","authors":"Stefano Moretto, Michele Zazzara, Filippo Marino, Arjan Nazaraj, Marcello Scarcia, Giuseppe M Ludovico","doi":"10.23736/S0026-4806.24.09291-7","DOIUrl":"10.23736/S0026-4806.24.09291-7","url":null,"abstract":"<p><strong>Background: </strong>Urolithiasis prevalence varies globally between 1-20%, influenced by regional factors. Robotic pyelolithotomy (RPL) presents an interesting alternative to PCNL, considered the gold standard for symptomatic stones smaller than 20 mm, as it carries a risk of significant complications. However, studies on RPL are limited, especially in anatomically complex cases, where RPL proves to be particularly useful. The study aims to update and review outcomes of RPL in a high-volume robotic center.</p><p><strong>Methods: </strong>A retrospective analysis of 153 patients treated with RPL for staghorn kidney stones at a single center from February 2016 to December 2023 was conducted. Data including demographics, preoperative renal function, stone characteristics, operative and postoperative outcomes, and costs were collected. Stone-free rates (SFR) and complications were assessed at follow-up intervals up to 12 months post-surgery.</p><p><strong>Results: </strong>The study showed an initial 3-month stone-free rate (SFR) of 93.5%, which decreased to 83.5% at 12-months. This trend may reflect new stone formation rather than procedure failure. Sub-analysis revealed a significant difference in SFR between patients with pelvic and pyelocalyceal stones at each follow-up. Multivariate regression analysis identified in the pyelocalyceal group that higher BMI and larger stones were associated with higher failure rates at both 6 and 12 months.</p><p><strong>Conclusions: </strong>RPL is a safe and effective treatment for large renal stones, offering a high SFR and low complication rate. It is particularly beneficial in cases with complex anatomy or requiring concurrent renal procedures. However, patient selection is crucial, considering factors like stone location and size. Further research is needed to compare RPL with other treatment methods.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141500040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the landscape of academic retractions in medicine: a comprehensive umbrella review. 探索医学界学术撤稿的现状:总括性综合评述。
Minerva medica Pub Date : 2024-10-01 Epub Date: 2024-07-02 DOI: 10.23736/S0026-4806.24.09343-1
Yashendra Sethi, Oroshay Kaiwan, Giacomo Frati, Mariangela Peruzzi, Mattia Galli, Mario Gaudino, Giuseppe Biondi-Zoccai
{"title":"Exploring the landscape of academic retractions in medicine: a comprehensive umbrella review.","authors":"Yashendra Sethi, Oroshay Kaiwan, Giacomo Frati, Mariangela Peruzzi, Mattia Galli, Mario Gaudino, Giuseppe Biondi-Zoccai","doi":"10.23736/S0026-4806.24.09343-1","DOIUrl":"10.23736/S0026-4806.24.09343-1","url":null,"abstract":"<p><strong>Introduction: </strong>The escalating trend of academic article retractions over the last decades raises concerns about scientific integrity, but heterogeneity in retractions and reasons for them pose a major challenge. We aimed to comprehensively overview systematic reviews focusing on retractions in the biomedical literature.</p><p><strong>Evidence acquisition: </strong>We abstracted salient features and bibliometric details from shortlisted articles. The Joanna Briggs Institute (JBI) Checklist for Systematic Reviews and Research Syntheses was used for validity appraisal.</p><p><strong>Evidence synthesis: </strong>A total of 11 reviews were included, published between 2016 and 2023, and reporting on a total of 1851 retracted studies. Several major reasons for retractions were identified, spanning both misconduct (e.g., falsification, duplication, plagiarism) and non-misconduct issues (e.g., unreliable data, publishing problems). Correlates include author-related factors (number of authors, nationality) and journal-related factors (impact factor), with repeat offenders contributing significantly. Impacts of retractions is profound, affecting scholarly credibility, public trust, and resource utilization.</p><p><strong>Conclusions: </strong>In order to prevent retractions and amend their adverse effects, rigorous and transparent reporting standards, enhanced training in research ethics, strengthened peer review processes, and the establishment of collaborative and integrated research integrity offices are proposed.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reflux disease: a new multicomponent solution for a multifaceted problem. 反流病:解决多方面问题的多成分新方案。
Minerva medica Pub Date : 2024-10-01 DOI: 10.23736/S0026-4806.24.09552-1
Ignazio LA Mantia, Attilio Varricchio, Cristina Luceri, Giorgio Ciprandi
{"title":"Reflux disease: a new multicomponent solution for a multifaceted problem.","authors":"Ignazio LA Mantia, Attilio Varricchio, Cristina Luceri, Giorgio Ciprandi","doi":"10.23736/S0026-4806.24.09552-1","DOIUrl":"https://doi.org/10.23736/S0026-4806.24.09552-1","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信